维普中文期刊产品整合服务
24篇 您的检索式:作者名="DEDOUSSIS C"
    题名 作者 年代 出处 被引量
1Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic显示文摘AIM: To assess the effects of mastic administration on cytokine production of circulating mononuclear cells of patients with active Crohn's disease (CD). METHODS: The study was conducted in patients with established mildly to moderately active CD, attending the outpatient clinics of the hospital, and in healthy controls. Recruited to a 4 wk treatment with mastic caps (6 caps/d, 0.37 g/cap) were 10 patients and 8 controls, all of who successfully completed the protocol. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), macrophage migration inhibitory factor (MIF) and intracellular antioxidant glutathione (GSH) were evaluated in peripheral blood mononuclear cells (PBMC) before and after treatment. RESULTS: Treating CD patients with mastic resulted in the reduction of TNF-α secretion (2.1 ± 0.9 ng/mL vs 0.5 ± 0.4 ng/mL, P = 0.028). MIF release was signif icantly increased (1.2 ± 0.4 ng/mL vs 2.5 ± 0.7 ng/mL, P = 0.026) meaning that random migration and chemotaxis of monocytes/macrophages was inhibited. No signifi cant changes were observed in IL-6, MCP-1 and GSH concentrations. CONCLUSION: This study shows that mastic acts as an immunomodulator on PBMC, acting as a TNF-α inhibitor and a MIF stimulator. Although further double-blind, placebo-controlled studies in a large number of patients is required to clarify the role of this natural product, this f inding provides strong evidence that mastic might be an important regulator of immunity in CD.Andriana C Kaliora Maria G Stathopoulou John K Triantaf illidis George VZ Dedoussis Nikolaos K Andrikopoulos 2007World Journal of Gastroenterology2007,13,45:8
2Chios mastic treatment of patients with active Crohn's disease显示文摘AIM: To evaluate the effectiveness of mastic administra-tion on the clinical course and plasma inflammatory me-diators of patients with active Crohn’s disease (CD).METHODS: This pilot study was conducted in patients with established mild to moderately active CD, attend-ing the outpatient clinics of the hospital, and in healthy controls. Ten patients and 8 controls were recruited for a 4-wk treatment with mastic caps (6 caps/d, 0.37 g/cap). All patients successfully completed the protocol. CD Ac-tivity Index (CDAI), Nutritional Risk Index (NRI), C-re-active protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), and total antioxidant potential (TAP) were evaluated in the plasma at baseline and at the end of the treatment period. Results were expressed as mean values ± SE and P < 0.05 was considered to indicate statistical significance.RESULTS: Patients exhibited significant reduction of CDAI (222.9 ± 18.7 vs 136.3 ± 12.3, P = 0.05) as com-pared to pretreament values. Plasma IL-6 was signifi-cantly decreased (21.2 ± 9.3 pg/mL vs 7.2 ± 2.8 pg/ mL, P = 0.027), and so did CRP (40.3 ± 13.1 mg/mL vs 19.7 ± 5.5, P = 0.028). TAP was significantly increased (0.15 ± 0.09 vs 0.57 ± 0.15 mmol/L uric acid, P = 0.036). No patient or control exhibited any kind of side effects. CONCLUSION: The results suggest that mastic signifi-cantly decreased the activity index and the plasma levels of IL-6 and CRP in patients with mildly to moderately ac-tive CD. Further double-blind, placebo-controlled studies in a larger number of patients are required to clarify the role of this natural product in the treatment of patients with CD.Andriana C Kaliora Maria G Stathopoulou John K Triantafillidis George VZ Dedoussis Nikolaos K Andrikopoulos 2007World Journal of Gastroenterology2007,13,5:7
3Dietary antioxidants in preventing atherogenesis 显示文摘KALIORA A C DEDOUSSIS G V Z SCHMIDT H 2006Atherosclerosis2006,187,1:1
4Gene-diet interactions in child- hood obesityPaucity of evidence as the epidemic of childhood obesity continues to rise显示文摘Apoutsakis C Dedoussis GV 2007Personalized Medicine2007,4,2:1
5Natural antioxidant compounds inrisk factors for CVD显示文摘KALIORA A C DEDOUSSIS G V 2007Pharmacological Research2007,56,2:1
6Natural antioxidant compounds in risk factors for CVD 显示文摘Kaliora A C Dedoussis G V 2007Pharmacological Research2007,56,2:1
7An associ ation between the methylenetetrahydrofolate reductase (MTHFR)C677T mutation and inflammation markers relat- ed to cardiovascular disease 显示文摘Dedoussis GV Panagiotakos DB Pitsavos C 2005Int J Cardiol2005,100,3:1
8Effect of phenols on natural killer (NK) cell-mediated death in the K562 leukemic cell line显示文摘DEDOUSSIS G V KALIORA A C ANDRIKOPOULOS N K 2005Cell Biol Int2005,29,11:1
9The detection of small round-structured viruses in water and environmental materials显示文摘WYN-JONES A P PALLIN R DEDOUSSIS C 2000J Virol Methods2000,87,12:1
10An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease显示文摘Dedoussis GV Panagiotakos DB Pitsavos C 2005Int J Cardiol2005,100,3:1
11APOE, CETP and LPL genes show strong association with lipid levels in Greek children 显示文摘Smart M C Dedoussis G Louizou E 2009Nutrition Metabolism & Cardiovascular Diseases2009,256,:1
12Dietary antioxidants in preventing atherogenesis 显示文摘KALIORA A C DEDOUSSIS G V SCHMIDT H 2006Atherosclerosis2006,187,:1
13The detection of small round-structured viruses in water and environmental materials显示文摘Wyn-Jones AP Pallin R Dedoussis C 0,,1:1
14Dietary antioxidants in preventing atherogenesis 显示文摘Kaliora A C Dedoussis G V Z Schmidt H 2006Atheroselerosis2006,187,:1
15The de- tection of small round-structured viruses in water and environ- mental materials 显示文摘WYN-JONES A P PALLIN R DEDOUSSIS C 2000J Virol Methods2000,87,12:1
16Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression 显示文摘George V Z Dedoussis Andriana C Kaliora Psarras S 2004Atherosclerosis2004,174,:1
17Induction of lym- phokine-activated killer activity in mice by prothymosin alpha 显示文摘Baxevanis C N Gritzapis A D Dedoussis G V 1994Cancer Immunol Immunother1994,38,:1
18Dietary antioxidants in preventing atherogenesis显示文摘Kaliora A C Dedoussis G V Z Schmidt H 2006Atheroscierosis2006,187,:1
19Effect of phenols on natural killer (NK) cell-mediated death in the K562 leukemic cell line显示文摘Dedoussis G V Kaliora A C Andrikopoulos N K 2005Cell Biol Int2005,,:1
20An association between the methylenetetrahydrofolate reductase(MTHFR)C677 T mutation and inflammation markers related to cardiovascular disease显示文摘Dedoussis GV Panagiotakos DB Pitsavos C 2005Int J Cardiol2005,100,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费